Purple Biotech Ltd.-ADRPPBT
13F holders, Q3 2025 (September 30)13holders +1
3new positions
2sold out
1famous investor
$0.57avg. 13F price*
At the end of Q3 2025, 13 institutions reported holding Purple Biotech Ltd.-ADR (PPBT) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Virtu Financial LLC ($28K), Citadel Advisors ($24K) and GAMMA Investing LLC ($7K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Purple Biotech Ltd.-ADR
- CUSIP
- 74638P208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $52K |
| Exits | 2 | $41K |
All 13F filers, Q2 2025 → Q3 2025: 110,177 shares bought and 34,549 shares sold, net +75,628 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Virtu Financial LLC | 0.00% | New | 48,993 | $28K |
| Citadel Advisors | 0.00% | New | 41,256 | $24K |
| GAMMA Investing LLC | 0.00% | Add +185.6% | 12,654 | $7K |
| BNP Paribas Financial Markets | 0.00% | Add +79.7% | 11,275 | $6K |
| Morgan Stanley | 0.00% | Add +142.4% | 11,066 | $6K |
| UBS Group AG | 0.00% | Reduce -74.3% | 5,947 | $3K |
| Rhumbline Advisers | 0.00% | No change | 1,080 | $614 |
| Tradewinds Capital Management, LLC | 0.00% | New | 100 | $58 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 85 | $49 |
| SBI Securities Co., Ltd. | 0.00% | No change | 20 | $11 |
| Global Retirement Partners, LLC | 0.00% | No change | 16 | $9 |
| Royal Bank of Canada | 0.00% | No change | 107 | $0 |
| Simplex Trading, LLC | 0.00% | Add +196.2% | 157 | $0 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd.-ADR the manager owns.